(ARR) ARMOUR Residential REIT - Ratings and Ratios
Residential MBS, Agency Securities, Treasuries, REIT
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 17.48% |
| Yield on Cost 5y | 12.56% |
| Yield CAGR 5y | 24.47% |
| Payout Consistency | 81.7% |
| Payout Ratio | 30.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.8% |
| Value at Risk 5%th | 35.1% |
| Relative Tail Risk | -1.86% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 3.71 |
| CAGR/Max DD | 0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.565 |
| Beta | 0.679 |
| Beta Downside | 0.882 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.46% |
| Mean DD | 20.98% |
| Median DD | 20.19% |
Description: ARR ARMOUR Residential REIT November 12, 2025
ARMOUR Residential REIT, Inc. (NYSE: ARR) is a mortgage-REIT that invests primarily in U.S. government-sponsored-entity (GSE) and Government National Mortgage Association (GNMA) securities, including fixed-rate, hybrid-adjustable, and fully adjustable-rate mortgage-backed securities, as well as unsecured GSE notes, Treasury securities, and money-market instruments. The REIT is taxed as a real-estate investment trust, meaning it avoids corporate income tax on the portion of net income distributed to shareholders. ARR was founded in 2008 and is headquartered in Vero Beach, Florida.
Key operational metrics as of the latest filing show a portfolio weighted-average duration of roughly 5.2 years, giving the fund moderate sensitivity to changes in the Federal Reserve’s policy rate. The dividend yield has hovered around 7–8 % over the past twelve months, while the distribution coverage ratio (DCR) remains above 1.0, indicating that cash flow from the MBS portfolio comfortably covers the declared payout. ARR’s net asset value (NAV) per share has been pressured by rising rates, but the REIT’s low leverage (≈ 30 % debt-to-assets) provides a buffer against further rate hikes.
If you want a data-driven, scenario-based assessment of ARR’s valuation and risk profile, checking out ValueRay’s analytical tools could be a worthwhile next step.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (64.5m TTM) > 0 and > 6% of Revenue (6% = 18.6m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -0.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5349 % (prev -77.13%; Δ -5272 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.01 (>3.0%) and CFO 179.1m > Net Income 64.5m (YES >=105%, WARN >=100%) |
| Net Debt (-44.2m) to EBITDA (565.6m) ratio: -0.08 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (104.6m) change vs 12m ago 101.7% (target <= -2.0% for YES) |
| Gross Margin 88.02% (prev 95.11%; Δ -7.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 1.89% (prev 4.98%; Δ -3.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.12 (EBITDA TTM 565.6m / Interest Expense TTM 595.8m) >= 6 (WARN >= 3) |
Altman Z'' -5.76
| (A) -0.86 = (Total Current Assets 123.9m - Total Current Liabilities 16.70b) / Total Assets 19.36b |
| (B) -0.04 = Retained Earnings (Balance) -729.9m / Total Assets 19.36b |
| (C) 0.00 = EBIT TTM 70.5m / Avg Total Assets 16.38b |
| (D) -0.04 = Book Value of Equity -729.8m / Total Liabilities 17.23b |
| Total Rating: -5.76 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.35
| 1. Piotroski 3.0pt |
| 2. FCF Yield 1.41% |
| 3. FCF Margin 57.78% |
| 4. Debt/Equity 5.03 |
| 5. Debt/Ebitda -0.08 |
| 6. ROIC - WACC (= -1.98)% |
| 7. RoE 3.77% |
| 8. Rev. Trend 60.28% |
| 9. EPS Trend 35.72% |
What is the price of ARR shares?
Over the past week, the price has changed by +2.64%, over one month by +11.88%, over three months by +24.48% and over the past year by +22.36%.
Is ARR a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ARR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.5 | -6.2% |
| Analysts Target Price | 17.5 | -6.2% |
| ValueRay Target Price | 24.3 | 30.5% |
ARR Fundamental Data Overview January 08, 2026
P/E Forward = 5.9453
P/S = 17.5597
P/B = 0.9577
P/EG = -1.31
Beta = 1.427
Revenue TTM = 309.9m USD
EBIT TTM = 70.5m USD
EBITDA TTM = 565.6m USD
Long Term Debt = unknown (none)
Short Term Debt = 16.56b USD (from shortTermDebt, last quarter)
Debt = 10.72b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -44.2m USD (from netDebt column, last quarter)
Enterprise Value = 12.72b USD (2.05b + Debt 10.72b - CCE 44.2m)
Interest Coverage Ratio = 0.12 (Ebit TTM 70.5m / Interest Expense TTM 595.8m)
EV/FCF = 71.04x (Enterprise Value 12.72b / FCF TTM 179.1m)
FCF Yield = 1.41% (FCF TTM 179.1m / Enterprise Value 12.72b)
FCF Margin = 57.78% (FCF TTM 179.1m / Revenue TTM 309.9m)
Net Margin = 20.83% (Net Income TTM 64.5m / Revenue TTM 309.9m)
Gross Margin = 88.02% ((Revenue TTM 309.9m - Cost of Revenue TTM 37.1m) / Revenue TTM)
Gross Margin QoQ = 93.75% (prev 95.16%)
Tobins Q-Ratio = 0.66 (Enterprise Value 12.72b / Total Assets 19.36b)
Interest Expense / Debt = 1.60% (Interest Expense 171.7m / Debt 10.72b)
Taxrate = 21.0% (US default 21%)
NOPAT = 55.7m (EBIT 70.5m * (1 - 21.00%))
Current Ratio = 0.01 (Total Current Assets 123.9m / Total Current Liabilities 16.70b)
Debt / Equity = 5.03 (Debt 10.72b / totalStockholderEquity, last quarter 2.13b)
Debt / EBITDA = -0.08 (Net Debt -44.2m / EBITDA 565.6m)
Debt / FCF = -0.25 (Net Debt -44.2m / FCF TTM 179.1m)
Total Stockholder Equity = 1.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.39% (Net Income 64.5m / Total Assets 19.36b)
RoE = 3.77% (Net Income TTM 64.5m / Total Stockholder Equity 1.71b)
RoCE = 2.65% (EBIT 70.5m / Capital Employed (Total Assets 19.36b - Current Liab 16.70b))
RoIC = 0.44% (NOPAT 55.7m / Invested Capital 12.80b)
WACC = 2.42% (E(2.05b)/V(12.77b) * Re(8.42%) + D(10.72b)/V(12.77b) * Rd(1.60%) * (1-Tc(0.21)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 45.81%
[DCF Debug] Terminal Value 87.52% ; FCFF base≈200.0m ; Y1≈227.3m ; Y5≈311.0m
Fair Price DCF = 82.19 (EV 9.15b - Net Debt -44.2m = Equity 9.20b / Shares 111.9m; r=5.90% [WACC]; 5y FCF grow 15.96% → 2.90% )
EPS Correlation: 35.72 | EPS CAGR: -34.03% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.28 | Revenue CAGR: 22.61% | SUE: 0.54 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.76 | Chg30d=+0.011 | Revisions Net=+1 | Analysts=6
EPS next Year (2026-12-31): EPS=3.13 | Chg30d=-0.006 | Revisions Net=+1 | Growth EPS=-0.3% | Growth Revenue=+82.0%
Additional Sources for ARR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle